Amneal Pharmaceuticals, Inc.
AMRX
$11.87
-$0.31-2.51%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.37M | 22.42M | 12.20M | -31.08M | -156.00K |
| Total Depreciation and Amortization | 54.07M | 60.11M | 60.16M | 66.13M | 58.96M |
| Total Amortization of Deferred Charges | 5.03M | 6.88M | 6.81M | 26.44M | 8.03M |
| Total Other Non-Cash Items | 107.72M | 29.52M | 34.62M | 34.74M | 32.17M |
| Change in Net Operating Assets | -50.74M | -35.11M | -106.38M | 21.86M | 42.77M |
| Cash from Operations | 118.45M | 83.82M | 7.41M | 118.08M | 141.77M |
| Capital Expenditure | -15.05M | -26.50M | -14.12M | -22.46M | -17.11M |
| Sale of Property, Plant, and Equipment | 0.00 | 855.00K | 524.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 7.01M | 0.00 |
| Other Investing Activities | -7.41M | -900.00K | -4.20M | -600.00K | -3.60M |
| Cash from Investing | -22.46M | -26.55M | -17.80M | -16.06M | -20.71M |
| Total Debt Issued | 2.70B | 0.00 | 218.00M | 0.00 | 0.00 |
| Total Debt Repaid | -2.55B | -15.55M | -235.53M | -55.54M | -87.21M |
| Issuance of Common Stock | 653.00K | 685.00K | 69.00K | 151.00K | 617.00K |
| Repurchase of Common Stock | -129.00K | -189.00K | -21.64M | -387.00K | -194.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.10M | -26.64M | -68.00K | -5.43M | -5.56M |
| Cash from Financing | 59.44M | -41.69M | -39.17M | -61.20M | -92.35M |
| Foreign Exchange rate Adjustments | -694.00K | -307.00K | -470.00K | -740.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.74M | 15.28M | -50.03M | 40.08M | 28.72M |